Latest Technology Commercialisation News

Archer Materials advances its quantum computing and medical diagnostics technologies, extending key partnerships and forming a new advisory board while maintaining a strong cash position to fuel development.

Green Critical Minerals’ proprietary VHD graphite heat sink outperforms traditional materials in computational tests, promising enhanced thermal management for high-power microchips in data centres.

MTM Critical Metals has appointed Gregory L. Bowman, a seasoned U.S. defense and industrial strategy expert, to the advisory board of its U.S. subsidiary Flash Metals USA, aiming to accelerate its critical metals refining technology and deepen ties with U.S. government stakeholders.

Metallium Ltd, formerly MTM Critical Metals, has upgraded its U.S. listing to the OTCQX Best Market, enhancing investor access and aligning with its expanding U.S. operations including a new Texas commercial site.

ClearVue Technologies has secured $746,574 through a mix of equity and debt to support its international commercialisation efforts amid shifting market conditions.

Anson Resources has partnered with POSCO Holdings to develop a demonstration plant for Direct Lithium Extraction at the Green River Lithium Project, aiming to validate new technology and boost US lithium supply.

Parkway Corporate Limited has secured over $13.5 million in water infrastructure contracts, including a major $12.85 million deal with a leading engineering firm, while advancing its innovative brine management technology and extending its loan facility to support expansion.

Global Uranium and Enrichment Limited is on the verge of finalizing a strategic partnership with uranium enrichment giant Urenco, securing a $5 million investment to accelerate Ubaryon’s innovative technology development.

Hazer Group has raised A$8 million through a share placement and launched a A$2 million Share Purchase Plan to accelerate its clean hydrogen and graphite technology commercialisation.

Enlitic, Inc. has launched a A$10 million placement alongside an offer of 125 million unquoted options, aiming to fuel growth in its AI-driven healthcare technology business. The move underscores both funding ambitions and the complex risks tied to AI adoption and market dynamics.

Control Bionics is on track for its strongest financial year yet, driven by robust US and Australian sales and promising global trials of its NeuroStrip® device.

Clean TeQ Water reports a successful lithium extraction pilot and the amicable termination of its LithiumBank agreements, setting the stage for new global deployments of its cDLE® technology.